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Jaundice occurs in approximately 85% of all term newborns and most of the preterms. Most of such cases are benign in nature; however, due to the potential toxicity of bilirubin, 
newborn infants must be monitored to identify those who might 
develop severe neonatal hyperbilirubinemia (NNH) resulting in 
neurotoxicity [1]. Pathological jaundice occurs in 5–25% of them. 
In most cases, it is benign and no intervention is required [2]. 
Approximately 5–10% of them have clinically significant NNH 
mandating intervention in the form of phototherapy or exchange 
transfusion. Unconjugated hyperbilirubinemia is potentially 
harmful for central nervous system and may result in kernicterus 
causing severe and permanent neurological sequelae [3].
Early prediction and identification of severe NNH for that 
age and appropriate treatment are must to prevent kernicterus, 
avoidance of aggressive managements, maternal anxiety, and 
unnecessary expenditures [4] and to reduce the duration of hospital 
stay [5]. Early discharge of healthy term newborns after delivery 
has become a common practice because of medical, social, and 
economical reasons. The most common cause for readmission 
during the early neonatal period is hyperbilirubinemia [6]. 
However, although early discharge from hospital may seem to 
be safe, the risk of severe NNH is an issue that still needs to be 
resolved and requires specific strategies to prevent a high morbidity 
rate [7]. There is currently little agreement about what constitutes 
safe bilirubin level because it is unclear at what level neurotoxicity 
develops and the condition under which toxicity develops, remains 
incompletely defined [8]. The bilirubin albumin ratio (BAR) is a 
surrogate parameter for free bilirubin and an interesting additional 
parameter in the management of NNH. Hence, we did this study to 
predict severe hyperbilirubinemia in healthy full-term neonates by 
comparing cord blood bilirubin and BAR.
MATERIALS AND METHODS
This prospective cross-sectional cohort study was conducted after 
obtaining clearance from the Institutional Ethical Committee, in a 
tertiary care center of Central India, over a period of 1 year. Written 
consent was obtained from parents of all the recruited neonates. 
The sample size was calculated using formula: n= t2 × P (1 – P)/m2.
The study population comprised of healthy term newborns 
(gestational age >37 weeks and weight >2.5 kg) of both genders. 
The exclusion criteria were preterm, low birth weight, and any 
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complication arising during the hospital stay that could aggravate 
the hyperbilirubinemia in these newborns (e.g., neonatal sepsis, 
ABO, Rh incompability, instrumental/traumatic delivery, and 
birth asphyxia), neonates with antenatal risk factors (meconium 
stained liquor), gestational hypertension, premature rupture 
of membrane, preeclampsia, anemia, malaria, maternal fever, 
chorioamnionitis, any other maternal illness, twins, gross 
congenital malformations, and/or comorbid illness, and neonates 
who developed jaundice within 24 h of life. Demographic profile 
and relevant maternal information were collected by interviewing 
the mothers and from mother’s case sheets. Gestational age was 
assessed by new Ballard scoring [9].
Sample (2 ml blood) was collected during the delivery from 
placental end of the cord in a clean, plain vial. Serum was separated 
by centrifuging at 3000 rpm; serum was stored in refrigerator 
at 4°C and tested for bilirubin and albumin, within 2 days after 
collection. Serum albumin was estimated using bromocresol 
green method and serum bilirubin by modified J and G Method. 
After this, BAR was calculated. All the babies were followed up 
daily for first 4 postnatal days and babies were daily assessed 
for jaundice and its severity. All neonates had undergone total 
serum bilirubin estimation at 72–96 h of age. The pathologist, 
who estimated serum bilirubin after 72 h, was unaware about the 
cord blood bilirubin level.
The main outcome of the study was inferred in terms of significant 
hyperbilirubinemia. Neonates with serum bilirubin ≥17 mg/dl at 
≥72 h of age were defined to have significant NNH and treatment 
was advised, as per the American Academy of Pediatrics [10]. All 
cases were recorded on a predefined pro forma which included 
gender, birth weight, gestational age, mode of delivery, and history 
of maternal use of oxytocin during labor, and history of neonatal 
jaundice in sibling was also obtained. All neonates were breastfed.
Statistical Analysis
The data of the present study were recorded, and after its 
proper validation, checked for error, coding and decoding were 
compiled and analyzed using the software SPSS 19 for windows. 
Appropriate univariate and bivariate analysis was carried out 
using the Student’s t-test for the continuous variable (age) and 
two-tailed Fisher exact test or Chi-square (χ2) test for categorical 
variables. All means were expressed as a mean±standard 
deviation. The critical levels of significance of the results were 
considered at 0.05 levels, i.e., p<0.05 was considered statistically 
significant. The sensitivity, specificity, positive predictive 
value (PPV), negative predictive values (NPVs), and diagnostic 
accuracy were calculated for both cord BAR and cord bilirubin 
alone. The comparison between three groups was done using 
ANOVA followed by Bonferroni test for multiple comparisons. 
All means are expressed as a mean ± standard deviation.
RESULTS
During the study period, a total of 1154 neonates were screened 
as shown in study flowchart in Fig. 1, and finally, 543 neonates 
were recruited. Demographic profile of the study population is 
presented in Table 1. Most of the neonates were of 1st birth order. 
Of 543 neonates, 44 (8.1%) neonates developed significant NNH. 
81% of the neonates, whose mothers had received oxytocin, 
developed significant NNH and 4 neonates, whose previous 
sibling had jaundice, also developed significant NNH (Table 2). 
Of 44 neonates who developed significant NNH, 13 received 
phototherapy and 31 underwent exchange transfusion. Of those 
neonates who developed significant NNH, 87.5% had cord BAR 
above the median value of 0.89 and 75% had cord blood bilirubin 
above the median value of 2.95 as summarized in Table 3.
Table 1: Demographic profile of the study population
Variables Number of patients (%)
Sex
Male 307 (56.5)
Female 236 (43.5)
Birth order
I 326 (60.0)
II 149 (27.5)
III or more 68 (12.5)
Birth weight (kg)
2.5–3 285 (52.5)
>3 258 (47.5)
Mode of delivery
Vaginal 380 (70)
Cesarean section 163 (30)
Table 2: Analysis of neonates with significant NNH
Parameters Total cases (%) Non-significant (%) Significant (%) p value Odds ratio
Oxytocin use
Yes 293 (51.6) 257 (81.3) 36 (54) 0.022 0.1669 (0.0760–0.3663)
No 250 (48.4) 242 (18.7) 8 (46)
H/o jaundice in previous sibling 
Yes 16 (8) 12 (6.5) 4 (25.0) 0.022 4.778 (1.3365–17.0803)
No 184 (92) 172 (93.5) 12 (75.0) 
Treatment given
Phototherapy 31 (97)
Exchange transfusion 13 (3)
NNH: Neonatal hyperbilirubinemia
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Table 4 presents the predictive values of cord BAR and cord 
blood bilirubin to detect NNH. Sensitivity and specificity of cord 
BAR were 95.45% and 89.78%. Sensitivity and specificity of 
cord blood bilirubin were 95.65% and 95.57%. PPV and NPV of 
cord BAR were 45.16% and 99.55%. PPV and NPV of cord blood 
bilirubin were 64.70% and 99.58%. Fig. 2 shows the sensitivity 
and specificity of bilirubin and albumin Ratio and Fig. 3 shows 
the sensitivity and specificity of Cord Bilirubin. All neonates 
included in the study were breastfed.
DISCUSSION
Higher cord blood bilirubin levels among infants who later 
become jaundiced compared to cord blood bilirubin levels in 
non-jaundiced infants indicate that some mechanisms for the 
subsequent jaundice are already active in late fetal life [11]. In 
the present study, 543 healthy neonates were included. Of these, 
44 (8%) developed significant NNH. A cord bilirubin level of 
>2.95 mg/dl predicts the development of significant jaundice 
(defined as bilirubin ≥17 mg/dl) with sensitivity and specificity: 
95.65% and 95.57% and PPV and NPV: 64.70% and 99.58%. 
Similar observation was noted by Taksande et al. in 2005 [12] 
with the cutoff value of 2.0 mg/dl, with sensitivity of 89.5%  and 
NPV of 98.7%. Hover, at the cutoff value of 2.0 mg/dl, 53% 
sensitivity was observed by Bernaldo and Segre in 2004 [6], 
and at 2.5 mg/dl, sensitivity of 71% and specificity of 96% were 
noted by Agarwal and Deorari in 2002 [1]. Rostami and Mehrabi 
in 2005 [13] noted that cord blood bilirubin level of 3 mg/dl 
(51.3 micromol/L) is not a useful predictor of neonatal jaundice. 
Venkatamurthy et al. [14] found that, at cord blood bilirubin 
level ≥2.1, sensitivity was 100, specificity 61.04, PPV 25, and 
NPV was 100.
Cord blood bilirubin level ≥2.5mg/dl appeared as high-risk 
indicator toward predicting NNH which was observed by 
Trivedi et al. [15] Rajpurohit et al. [16] noted that at cord 
blood bilirubin level of >2 mg/dl had a sensitivity of 90%, 
specificity of 53.89%, PPV 17.8%, and NPV of 98% in 
predicting the risk of NNH (p<0.001). The sensitivity of cord 
BAR in predicting future significant hyperbilirubinemia is 
95.45%. Considering a cutoff point of cord BAR 0.89, if the 
cord BAR is above 0.89, 95.5% of patients can develop future 
significant NNH.
It was observed in the present study that history of jaundice 
in the previous sibling was found in 25% of cases in significant 
group, while it was observed only in 6.5% of non-significant 
NNH group. This was statistically (p=0.022) significant. This 
is in accordance with the American Academy of Pediatric 
guidelines; history of previous sibling with NNH occupies 
the major and minor risk factor to develop severe NNH. In 
the present study, it was observed that incidence of significant 
NNH was higher in those neonates in whom mother received 
intrapartum oxytocin (p=0.022). The incidence of significant 
NNH was 81.3% in them as compared to 51.6% in non-
significant NNH group.
Table 3: Distribution of cases according to BAR and cord bilirubin
Value Significant NNH (%) Non-significant NNH (%) Total (%) P value
Cord BAR (median value - 0.89)
>0.89 39 (87.5) 249 (50) 288 (53) <0.01
<0.89 5 (12.5) 250 (50) 255 (47)
Cord bilirubin (median value - 2.95)
>2.95 33 (75) 228 (45.7) 261 (48.5) <0.05
<2.95 11 (25) 271 (54.3) 282 (51.5)
Total 44 (100) 499 (100) 543 (100)
NNH: Neonatal hyperbilirubinemia, BAR: Bilirubin albumin ratio
Table 4: Statistical values of cord BAR and cord bilirubin
Tests Sensitivity (%) Specificity (%) PPV (%) NPV (%) LR+ LR_ DOR
Bilirubin 95.45 89.78 45.16 99.55 9.340 0.051 184.4
Albumin ratio (84.87–98.74) (86.81–92.14) (7.144–12.209) (0.013–0.196) (43.367–784.682)
Cord 95.65 95.57 64.70 99.58 21.609 0.045 475.00
Bilirubin level (85.47–98.80) (93.39–97.06) (14.926–32.663) (0.012–0.176) (108.116–2086.885)
BAR: Bilirubin albumin ratio, NPV: Negative predictive value, PPV: Positive predictive value
Figure 1: Study flowchart
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CONCLUSION
We conclude that, at the cutoff value of 0.89, cord BAR had good 
sensitivity and NPV, and at the cutoff value of 2.59, cord total 
bilirubin alone has more specificity and diagnostic accuracy. 
Both, the cord BAR and cord blood bilirubin, are early predictors 
of significant NNH; however, cord blood bilirubin was found to 
be a better tool.
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